A federal judge has rejected an attempt by C.R. Bard Inc. to halt a bellwether trial due to comments he made in court that were published in an online news article.
Bard is one of seven manufacturers sued over pelvic mesh devices, which are implanted in women to treat pelvic organ prolapse and urinary incontinence. Bard, which faces 10,000 lawsuits, is set to go to trial on Feb. 18 against an Ohio woman who claims she suffered pain and urinary problems after having its Avaulta device implanted in 2007.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
